Magventure rTMS – Distributed by Roxon used in Mental Health Research

Click on the image above to view the news article and video link.
“In an effort to help people living with treatment-resistant depression – those who have failed to respond to one or more different antidepressant medications – Dr. Sara Tremblay, a scientist at The Royal’s Institute of Mental Health Research, has been tirelessly working for the past two years to bring an rTMS clinical-research platform to The Royal.”

As always Roxon is proud to have an experienced Neuro Specialist who is in continuous, close dialogue with MagVenture to provide support, advice and products to our clients.

Please do not hesitate to reach out to us for more information.